NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Nicolaus KrögerAlan S Wayne

Abstract

Relapse has become the major cause of treatment failure after allogeneic hematopoietic stem cell transplantation. Outcome of patients with clinical relapse after transplantation generally remains poor, but intervention prior to florid relapse improves outcome for certain hematologic malignancies. To detect early relapse or minimal residual disease, sensitive methods such as molecular genetics, tumor-specific molecular primers, fluorescence in situ hybridization (FISH), and multiparameter flow cytometry (MFC) are commonly used after allogeneic stem cell transplantation to monitor patients, but not all of them are included in the commonly employed disease-specific response criteria. The highest sensitivity and specificity can be achieved by molecular monitoring of tumor- or patient-specific markers measured by polymerase chain reaction-based techniques, but not all diseases have such targets for monitoring. Similar high sensitivity can be achieved by determination of recipient-donor chimerism, but its specificity regarding detection of relapse is low and differs substantially among diseases. Here, we summarize the current knowledge about the utilization of such sensitive monitoring techniques in chronic leukemias, myeloproliferat...Continue Reading

References

Mar 1, 1992·Radiology·H I LibshitzJ E Husband
Mar 1, 1980·Radiology·J M WoolfendenT E Moon
Jul 1, 1995·Cancer Genetics and Cytogenetics·J R SawyerB Barlogie
Feb 19, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·J L SchultzeJ G Gribben
May 7, 1999·Bone Marrow Transplantation·A S Yong, J M Goldman
Aug 12, 1999·British Journal of Haematology·F E LecouvetB C Vande Berg
Feb 14, 2003·Lancet·Arthur R BradwellMark T Drayson
May 10, 2003·Blood·Paolo CorradiniUNKNOWN Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ScheteligUNKNOWN Cooperative German Transplant Study Group
Oct 10, 2003·The New England Journal of Medicine·Tim P HughesUNKNOWN International Randomised Study of Interferon versus STI571 (IRIS) Study Group
Nov 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Holger SchirrmeisterMartin Bommer
Mar 3, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Elena G ChioreanJeffrey S Miller
Jul 24, 2004·Hematology/oncology Clinics of North America·Jerald P RadichJane F Apperley
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorDavid G Maloney
Jun 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Terpos, M-A Dimopoulos
Jun 14, 2005·European Journal of Radiology·Andrea Baur-MelnykMaximilian Reiser
Jun 23, 2005·Journal of Magnetic Resonance Imaging : JMRI·Sílvia Nosàs-GarciaStefan Delorme
Sep 30, 2005·The New England Journal of Medicine·Ayalew TefferiGary Gilliland
Dec 20, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins

❮ Previous
Next ❯

Citations

Dec 16, 2010·Current Opinion in Oncology·Nicolaus Kröger
Mar 29, 2014·Annals of Hematology·Maximilian ChristopeitUlrike Bacher
Jan 29, 2011·Expert Opinion on Biological Therapy·Claire Roddie, Karl S Peggs
Sep 17, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alan S WayneMichael R Bishop
Nov 5, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolaus KrögerMichael R Bishop
Jan 13, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael R BishopSergio Giralt
Jul 14, 2012·Blood·Alan S Wayne, Jerald P Radich
Mar 3, 2015·Bone Marrow Transplantation·I PessachA Nagler
Nov 3, 2005·Clinics in Chest Medicine·Corey Cutler, Joseph H Antin
Jan 27, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Seth M PollackMichael R Bishop
May 4, 2018·Bone Marrow Transplantation·Lea SellmannLothar Hambach
Jan 11, 2019·International Journal of Molecular Sciences·Christina RautenbergThomas Schroeder

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

© 2021 Meta ULC. All rights reserved